Skip to main content

Table 3 Blood pressure control and use of antihypertensive medication among CKD patients with hypertension according to level of UACR

From: Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study

Characteristics

Overall, n (%, 95% CIs)

UACR, mg/mmol, n (%, 95% CIs)

<3.0

≥ 3.0

≥3.0 and diabetes

n = 267

N = 56

N = 211

N = 107

BP ≤ 140/90 mm Hg, n (%, 95% CI)

51 (19.1, 14.6 – 24.3)

13 (23.2, 13.0 – 36.4)

38 (18, 13.1 – 23.9)

20 (18.7, 11.8 – 27.4)

BP ≤ 130/80 mm Hg, n (%, 95% CI)

17 (6.4, 3.8 – 10.0)

6 (10.7, 4.0 – 21.9)

11 (5.2, 2.6 – 9.1)

6 (5.6, 2.1 – 11.8)

Use of antihypertensive medications, n (%, 95% CI)

130 (48.7, 42.6 – 54.9)

33 (58.9, 45.0 – 71.9)

97 (46, 39.1 – 52.9)

54 (50.5, 40.6 – 60.3)

  1. UACR = Urinary Albumin to Creatinine Ratio; BP = Blood Pressure.
  2. CKD (G3, A2 or worse) is defined as the eGFR < 60 mL/min/1.73 m2 estimated by CKD-EPIPK equation (0.686 × CKD-EPI1.059) or UACR ≥3 mg/mmol.
  3. Patients with diabetes mellitus and UACR ≥3 mg/mmol along with CKD and hypertension.